EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Macrolide Resistance from the Ribosome Perspective

F Franceschi, Z Kanyo, E C Sherer, J Sutcliffe

Current Drug Target -Infectious Disorders · 01.09.2004 · 4 (3) · 177-191

DOI: 10.2174/1568005043340740 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, erschienen am 01.09.2004. Verfasst von F Franceschi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rib-X Pharmaceuticals, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA. Die Arbeit wurde bisher 63-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrolides are important antibiotics used in treatment of respiratory tract infections in humans. Although some of these compounds have been in use for 50 years, it has not been until the last few years that their mechanism of action and the nature of ribosomal-based resistance could be more fully understood. With the advent of robust crystals of ribosomal 50S subunits, and structural resolution of macrolides and ketolides complexed to either Haloarcula marismortui or Deinococcus radiodurans 50S, the ability to dissect the binding modes and understand resistance at the level of the ribosome became possible. This review article compares the binding features of 14-, 15-, and 16-membered macrolides to that of ketolides telithromycin and ABT-773 as revealed at the atomistic level. Attempts to understand how modifications to 23S rRNA and/or mutations in ribosomal proteins L4 and L22 that have been found to confer resistance in Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae are told from the perspective of the ribosome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialHumansMacrolidesMutationRibosomes

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • Rib-X Pharmaceuticals, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA.

Zitieren

APA

Franceschi, F., Kanyo, Z., Sherer, E. C., & Sutcliffe, J. (2004). Macrolide Resistance from the Ribosome Perspective. Current Drug Target -Infectious Disorders, 4(3), 177-191. https://doi.org/10.2174/1568005043340740

Vancouver

Franceschi F, Kanyo Z, Sherer EC, Sutcliffe J. Macrolide Resistance from the Ribosome Perspective. Current Drug Target -Infectious Disorders. 2004;4(3):177-191. doi:10.2174/1568005043340740

BibTeX
@article{Franceschi2004,
  author = {Franceschi, F and Kanyo, Z and Sherer, E C and Sutcliffe, J},
  title = {Macrolide Resistance from the Ribosome Perspective},
  journal = {Current Drug Target -Infectious Disorders},
  year = {2004},
  volume = {4},
  number = {3},
  pages = {177--191},
  doi = {10.2174/1568005043340740}
}
Kostenlos starten →